Skip to main content
padlock icon - secure page this page is secure

Advances in Immunotherapy for Systemic Disorders

Buy Article:

$31.50 + tax (Refund Policy)

The improved understanding of immunologic mechanisms has been accompanied by less dramatic developments in immunotherapy. Recent developments are reviewed in passive immunization, active immunization, immunologic reconstitution and immunopotentiators. The most important new agents include intravenous gammaglobulin, VIC, HBIG, inactivated hepatitis B vaccine and zinc. Promising agents include the use of E rosetting and soybean agglutinin prepared bone marrow, TP5, interferon, and a variety of immunopotentiators.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Affiliations: R. A. Cooke Institute of Allergy, St. Luke's–Roosevelt Hospital Center, New York, New York; Div. Allergy & Clinical Immunology, Div. of Infectious Dis. & Epidemiology, St. Luke's–Roosevelt Hospital Center, New York, New York; Clinical Medicine, Columbia University College of Physicians & Surgeons, New York, New York

Publication date: 01 December 1983

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more